Astrazeneca Ab

Inger Kers

Yevgeni Besidski

Martin Nylöf

Karin Skogholm

Andrew Griffin

Shawn Donald Johnstone

Denis Labrecque

Paul Jones

Lars Sandberg

Martin Nylof

Didier Rotticci

Mats Svensson

Andis Slaitas

The present invention relates to new compounds or salts, solvates or solvated salts thereof, processes for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds in therapy.

Compounds

The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. 

N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain

Compounds of formula I, wherein R, m, R, R, p, n, Rand Rare as defined as in the specification, salts, solvates or solvated salts thereof, processes for their preparation, intermediates used in the preparation thereof, pharmaceutical formulations containing said compounds and the use of said compounds in therapy.

Benzimidazole derivatives

Growing community of inventors

Sodertalje, Sweden

Inger Kers